comparemela.com
Home
Live Updates
Instylla Announces Enrollment of Initial Patient in the Prospective Multicenter HALT Study : comparemela.com
Instylla Announces Enrollment of Initial Patient in the Prospective Multicenter "HALT" Study
/PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the...
Related Keywords
Boston ,
Massachusetts ,
United States ,
Bedford ,
American ,
Suvranu Ganguli ,
David Tahour ,
David Cao ,
Qian Yu ,
Timothy Jarrett ,
Eric John Gandras ,
Jeffrey Leef ,
Raymond Lareau ,
Steven Zangan ,
Amar Sawhney ,
Rakesh Navuluri ,
Amanda Zhang ,
Brian Funaki ,
Instylla Inc ,
American Association For The Surgery Of Trauma ,
Boston Medical Center ,
Memorialcare Long Beach Medical Center ,
Prnewswire Instylla Inc ,
Hydrogel Embolic System ,
Multicenter Single Arm Study ,
Embolic System ,
Solid Organs ,
American Association ,
Interventional Radiology ,
Memorialcare Long Beach Medical ,
Section Chief ,
Boston Medical ,
Embrace Hydrogel Embolic System ,
Basic Principles ,
Semin Intervent ,
Transcatheter Embolization ,
Acute Arterial Upper Gastrointestinal Bleeding ,
Osman Ahmed American Journal ,
John Gandras ,
Hydrogel Liquid Embolic Agent ,
Porcine Mesenteric Hemorrhage Model ,
Instylla ,
Nc ,
comparemela.com © 2020. All Rights Reserved.